The Bills

For over a decade, national advocacy groups and local rare disease networks have attempted to pass legislation establishing a Rare Disease Advisory Council (RDAC) in Olympia. Despite bipartisan sponsorship and repeated introductions, Washington’s legislative record reveals a persistent pattern: high-profile bill introductions followed by fiscal committee stalls.

Here is a breakdown of the specific legislative efforts, how the bills were structured, and where they broke down in the lawmaking process.

Senate Bill 5064 / House Bill 1238: The Modern Framework

Status: Introduced; failed to pass due to budget constraints.

Senate Bill 5064 (and its companion HB 1238) represents the most refined attempt to date. Drafted directly with input from patient advocacy groups and life science leaders, the bill was specifically designed to bypass previous administrative hurdles by shifting responsibility away from state agencies and onto academic research centers.

Earlier Attempts: SB 5886 & SB 5097

Status: Died in committee in previous legislative bienniums.

Before SB 5064, earlier iterations of the RDAC bill took a more traditional administrative approach:

• The Department of Health Approach: Initial legislation attempted to embed the advisory body directly into the Department of Health structure.

• The Downfall: These earlier versions faced stiff pushback during fiscal reviews. DOH fiscal notes highlighted significant administrative overhead, costs associated with state staff dedicated to council operations, and potential jurisdictional overlap with existing public health programs.

Why Does It Fail?

▼ [ STEP 1: Introduction & Co-Sponsorship ] Supported by bipartisan lawmakers in both houses.

▼ [ STEP 2: Senate Policy Committee Approval ] Passes the Health & Long-Term Care Committee with a unanimous "DO PASS" recommendation.

▼ [ STEP 3: Ways & Means / Fiscal Committee ] ◄─── Bottle-neck fiscal note attached. Bill is put on hold during budget negotiations.

▼ [ RESULT: Session Adjournment ] Time expires before reaching a full floor vote; the bill dies and must be reintroduced.

The Traps

-The Fiscal Note Trap: Even when advocates tailored SB 5064 to narrow its scope—reducing administrative costs by leveraging UW infrastructure—fiscal committees evaluated the bill against state budget deficits. Because an advisory council generates long-term system savings rather than immediate cash revenue, budget writers deprioritized funding it.

-The "Non-Mandatory" Designation: Unlike legislation addressing court mandates, federal requirements, or immediate emergency responses, advisory council bills are categorized as discretionary policy. When floor schedules tighten at the end of a session, discretionary policy bills are the first to be dropped from the voting calendar.

-Competing Newborn Screening & Biomarker Bills: The RDAC bill was not dying in isolation. Associated rare disease legislation—such as bills seeking state coverage for biomarker testing (HB 1062) and enhanced newborn screening funding (HB 1697)—similarly failed due to projected short-term costs to state health plans.